A Clinical study to evaluate efficacy and safety of Ayulax Capsule in the Management of Functional Constipation - NI

Welex Laboratories Pvt Ltd0 个研究点目标入组 36 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Subjects presenting with two or more of the following for the last 3 months with symptom onset at least 6 months prior to diagnosis
•a. Straining during at least 25 percent of defecations
•b. Lumpy or hard stools at least 25 percent of defecations
•c. Sensation of incomplete evacuation at least 25 percent of defecations
•d. Sensation of anorectal blockage at least 25 percent of defecations
•e. Manual maneuvers to facilitate at least 25 percent of defecations
•f. Fewer than three defecations per week
•2. Subjects having stool form between 1 to 3 on the Bristol Stool Form Scale

•1. Subjects with diagnosed colonic inertia.
•2. Subjects who have recently undergone abdominal surgery
•3. Subjects with history of anorectal surgery.
•4. Subjects having other functional gastrointestinal disorders other than Functional constipation (i.e. IBS, Belching disorders etc.)
•5. Subjects with serious uncontrolled & diagnosed systemic ailments like HIV, DM and Tuberculosis.
•6. Subjects with renal or liver dysfunction
•7. Pregnant or lactating females
•8. Subjects with disturbed thyroid functions

发起方

Welex Laboratories Pvt Ltd